MYO MYOMO, INC.

NYSE myomo.com


$ 0.82 $ 0.01 (0.93 %)    

Friday, 14-Nov-2025 15:51:47 EST
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 0.8159
$ 0.80
$ 0.82 x 100
$ 0.82 x 103
$ 0.78 - $ 0.83
$ 0.78 - $ 7.17
756,619
na
31.36M
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 03-10-2025 12-31-2024 10-K
5 11-06-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-08-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-13-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-03-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-11-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-05-2021 03-31-2021 10-Q
20 03-10-2021 12-31-2020 10-K
21 11-10-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-14-2020 03-31-2020 10-Q
24 03-13-2020 12-31-2019 10-K
25 11-12-2019 09-30-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-14-2019 03-31-2019 10-Q
28 03-12-2019 12-31-2018 10-K
29 11-07-2018 09-30-2018 10-Q
30 08-08-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-12-2018 12-31-2017 10-K
33 11-08-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 myomo-affirms-fy2025-sales-guidance-of-40000m-42000m-vs-40188m-est

Myomo (AMEX:MYO) affirms FY2025 sales outlook from $40.000 million-$42.000 million to $40.000 million-$42.000 million vs $40.18...

 myomo-q3-eps-009-inline-sales-10091m-beat-9438m-estimate

Myomo (AMEX:MYO) reported quarterly losses of $(0.09) per share which met the analyst consensus estimate. This is a 200 percent...

 a-peek-at-myomos-future-earnings
A Peek at Myomo's Future Earnings
11/07/2025 19:06:16

 ascendiant-capital-maintains-buy-on-myomo-lowers-price-target-to-105

Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and lowers the price target from $11.5 to $10.5.

 crude-oil-down-1-gevo-shares-spike-higher

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 1% on Tuesday. The Dow traded up 1....

 dow-surges-500-points-us-core-inflation-rises-to-31

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 1% on Tuesday. The Dow traded up 1...

 hc-wainwright--co-maintains-buy-on-myomo-lowers-price-target-to-5

HC Wainwright & Co. analyst Sean Lee maintains Myomo (AMEX:MYO) with a Buy and lowers the price target from $9.5 to $5.

 myomo-shares-plunge-over-42-pre-market-despite-q2-revenue-beat-amid-weak-outlook-rising-losses

Myomo's stock dropped over 42% during pre-market trading despite beating second-quarter revenue expectations.

 myomo-lowers-fy2025-sales-guidance-from-50000m-53000m-to-40000m-42000m-vs-49208m-est

Myomo (AMEX:MYO) lowers FY2025 sales outlook from $50.000 million-$53.000 million to $40.000 million-$42.000 million vs $49.208...

 myomo-sees-q3-sales-9500m-10000m-vs-12855m-est

Myomo (AMEX:MYO) sees Q3 sales of $9.500 million-$10.000 million vs $12.855 million analyst estimate.

 myomo-q2-eps-011-inline-sales-9652m-beat-9147m-estimate

Myomo (AMEX:MYO) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 266.67 perc...

 craig-hallum-maintains-buy-on-myomo-lowers-price-target-to-8

Craig-Hallum analyst Craig Knickerbocker maintains Myomo (AMEX:MYO) with a Buy and lowers the price target from $10 to $8.

 myomo-sets-financial-goals-targeting-100m-annual-revenue-by-2028-with-70-72-gross-margin-15-20-ebitda-margin-and-cash-flow-breakeven-at-17m-18m-quarterly-revenue

Management will present a long-range financial model, with the goal of $100 million in annual revenue by 2028. Elements of the ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION